MicroRNA-494 And CREB Pathway: A Role In The Anxiolytic-like Effects Of Acute Ethanol | 18079
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2464

Journal of Addiction Research & Therapy received 2464 citations as per Google Scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

MicroRNA-494 and CREB pathway: A role in the anxiolytic-like effects of acute ethanol

3rd International Conference and Exhibition on Addiction Research & Therapy

Tara Teppen, H R Krishnan, H Zhang, A J Sakharkar and S C Pandey

Posters: J Addict Res Ther

DOI: 10.4172/2155-6105.S1.018

R egulation of gene expression by microRNAs (miRNA) is an important epigenetic mechanism that could mediate chromatin remodeling leading to modulation of synaptic plasticity. The involvement of miRNA-494 as a possible chromatin remodeler was investigated via its actions on gene targets that in-turn could affect synaptic plasticity in the amygdala leading to the anxiolytic effects observed after acute ethanol exposure. Adult male Sprague-Dawley rats were intraperitoneally injected with ethanol (1g/kg) or n-saline and one hour after the injection, rats were subjected to anxiety-like behavioral measurements and amygdala tissue was immediately collected. Acute ethanol exposure resulted in a significant down-regulation of mature miRNA-494 mRNA within the amygdala. In order to further examine the downstream effects of miR-494, miR-494 function was next inhibited through the infusion of a locked nucleic acid (LNA) modified antagomir directly into the central nucleus of amygdala (CeA). Rats received four bilateral CeA infusions of either aCSF, scrambled antagomir (500 pmol) or miRNA-494 antagomir (500 pmol) in the morning and evening for two consecutive days. On the third day, behavioral tests were performed and brains were immediately removed for biochemical analysis. Inhibition of miRNA-494 in the CeA was able to mimic the behavioral effects of ethanol by producing an anxiolytic response. No change was observed following infusion of the scrambled antagomir. One of the predicted target genes of miR-494 is Cited2 ( CBP/p300 - interacting transactivator 2) a novel candidate gene that regulates CREB signaling. mRNA expression of Cited2 and Cited2-related signaling genes such as CBP ( cAMP response element binding protein) and p300 was therefore measured. Protein levels of CBP and p300 were also measured. The mRNA levels of CBP , p300 and Cited2 were up-regulated in both the ethanol and antagomir groups. Protein levels of CBP and p300 corroborated these results. Increases in levels of histone acetyltransferases ( CBP and p300 ) following CeA antagomir infusion indicates a role of miR-494 signaling in chromatin remodeling. These results suggest a novel CREB pathway regulator in the amygdala which is possibly involved in anxiolytic effects of ethanol

Tara Teppen is a Senior Research Scientist in the Department of Psychiatry at the University of Illinois at Chicago and Jesse Brown VA Medical Center, where she is currently studying the molecular mechanisms of acute and chronic alcohol use and withdrawal. She received her PhD in Neuroscience from Rosalind Franklin University and conducted two Postdoctoral trainings in the Department of Psychiatry at the University of Illinois at Chicago and in Research and Development at Jesse Brown VA Medical Center.